ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0080

Enhanced Cytotoxicity of Aging Associated NKG2C+ CD8+ T Cells in Ankylosing Spondylitis via HLA-B27

Kunhai Tang, Xiaobei Ma, Jian Gao, Feng Qian, Qi Zhu, Jiucun Wang and Jing Liu, Fudan University, Shanghai, China (People's Republic)

Meeting: ACR Convergence 2024

Keywords: Ankylosing spondylitis (AS), Collagen-Induced Arthritis, Cytotoxic Cells, spondyloarthritis, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Basic Science Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Ankylosing spondylitis (AS) is an immune-related chronic inflammatory disease characterized by inflammatory pain in the lower back and spinal ankylosing, accompanied by immune system disorders, such as increased inflammatory cytokines and changes in the composition of immune cell subsets. The aging process is associated with immune system aging, which has been previously linked to autoimmune diseases. It remained unknown whether aging process was present in AS and played a pathogenic role. The aim of this study was to investigate the possible mechanism of involvement in AS pathogenesis.

Methods: Peripheral blood mononuclear cell (PBMC) single-cell sequencing and peripheral blood multi-dimensional flow cytometry were performed in AS patients and healthy controls to identify the different cell populations in AS patients. The phenotype and function of NKG2C+CD8+T cells were detected by flow cytometry. Cytotoxicity was determined by the expression of CD107a. HLA-B27 over-expressed K562 cell line was constructed by lentivirus transfection, the effect of HLA-B27 on the function of NKG2C+CD8+T cells was verified by in vitro cell co-culture experiment. Immunofluorescence staining was used to determine the infiltration of Ly49h+ cells in the disease site of collagen-induced arthritis(CIA) mice.

Results: Through a comprehensive analysis peripheral blood multi-dimensional flow panel, we found that the distribution of subsets of CD8+T cells were significantly associated with aging and was abnormal in both AS and psoriasis (Ps) patients. Based on scRNA-seq, we identified the PI3K-Akt signaling pathway and endocytosis pathways of NKG2C+CD8+T cell subset – a well-known aging associated cell type – were activated in AS (Figure 1). Furthermore, we found that the cytotoxicity of this subset was significantly higher in AS with in vitro stimuli. Importantly, we found that the presenting cells with the HLA-B27 molecule led to increased cytotoxicity of this subset, which was diminished with the inhibition of NKG2C.This indicates that NKG2C+CD8+T cells are important effector cells for HLA-B27, and inhibition of NKG2C represents a novel potential target (Figure 2). Additionally, these results were consistent with findings in HLA-B27 transgenic mice, where Ly49h+ cells, a homologous receptor with a similar function to human NKG2C, infiltrated the disease site of CIA mice.

Conclusion: The NKG2C+CD8+T cell subgroup – an aging associated subset, acquires cytotoxic potential with HLA-B27 stimulation. Inhibition of NKG2C represents a novel potential target for AS treatment.

Supporting image 1

Figure1 a) Correlation between cell type proportions and age in healthy controls. Cell types are listed in descending order based on the absolute value of their correlation coefficients with age. b) Comparison of the proportions of five different cell types in peripheral blood between AS patients, Psoriasisi patients and healthy controls. c) UMAP plot of KLRC2+GZMB+, Tmem-KLRC2 and others. d) Gene Set Enrichment Analysis (GSEA) in the peripheral blood from AS patients and healthy controls. e) Expression levels of the LAMP1 gene in KLRC2+GZMB+, Tmem-KLRC2, and other cell subsets between AS patients and healthy controls. Statistical significance was determined using the Wilcoxon signed-rank test. *** P < 0.005, ** P < 0.01, * P < 0.05.

Supporting image 2

Figure2 Enhanced function of NKG2C+CD8+ T cells in patients with AS and their association with HLA-B27. a) Proportion of NKG2C+ CD8+T cells expressing CD107a in AS patients and healthy controls. b) The proportion of CD107a in NKG2C+CD8+ T cells was detected by co-culture of PBMC from healthy subjects with NC-K562 and HLA-B27-K562 cells. c) The killing ability of NKG2C+T cells was detected by co-culture with NC-K562 and HLA-B27-K562, and the killing percentage was calculated by the follows:Specific lysis%=Total lysis%- Spontaneous lysis%. Statistical significance was determined using the Wilcoxon signed-rank test. *** P < 0.005, ** P < 0.01, * P < 0.05.


Disclosures: K. Tang: None; X. Ma: None; J. Gao: None; F. Qian: None; Q. Zhu: None; J. Wang: None; J. Liu: None.

To cite this abstract in AMA style:

Tang K, Ma X, Gao J, Qian F, Zhu Q, Wang J, Liu J. Enhanced Cytotoxicity of Aging Associated NKG2C+ CD8+ T Cells in Ankylosing Spondylitis via HLA-B27 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/enhanced-cytotoxicity-of-aging-associated-nkg2c-cd8-t-cells-in-ankylosing-spondylitis-via-hla-b27/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-cytotoxicity-of-aging-associated-nkg2c-cd8-t-cells-in-ankylosing-spondylitis-via-hla-b27/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology